Vasista Vittal 4
4 · REGENXBIO Inc. · Filed Mar 21, 2024
Insider Transaction Report
Form 4
REGENXBIO Inc.RGNX
Vasista Vittal
See Remarks
Transactions
- Exercise/Conversion
Employee Stock Option (Right to Buy)
2024-03-19−20,041→ 0 totalExercise: $3.76Exp: 2025-05-19→ Common Stock (20,041 underlying) - Exercise/Conversion
Common Stock
2024-03-19$3.76/sh+20,041$75,354→ 246,534 total
Footnotes (1)
- [F1]The previously granted option, representing a right to purchase a total of 30,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on May 19, 2016, and the balance vested in equal monthly installments over the 36 months thereafter.